Shree Ganesh Remedies to meet Moneybee Investment Advisors on June 30

0 min read Updated on 25 Jun 2026, 08:52 PM

Reviewed by

Suketu GScanX News Team

AI Summary

Shree Ganesh Remedies Limited will engage with Moneybee Investment Advisors on June 30, 2026, at Ankleshwar. The meeting adheres to SEBI regulations regarding disclosures.

*this image is generated using AI for illustrative purposes only.

Shree Ganesh Remedies Limited will hold a meeting with Moneybee Investment Advisors on June 30, 2026, at Ankleshwar. The management interaction aims to discuss business updates and performance with the institutional investor.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The meeting is part of the company's ongoing engagement with the investment community.

Meeting Schedule

Date of Meeting	Interaction with
June 30, 2026	Moneybee Investment Advisors

Aditya Vikrambhai I Patel, Company Secretary of Shree Ganesh Remedies Limited, confirmed the schedule in a filing to BSE Limited.

Historical Stock Returns for Shree Ganesh Remedies

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.43%	+6.94%	+11.35%	+54.83%	+17.67%	+98.35%

What key business updates is Shree Ganesh Remedies likely to present to Moneybee Investment Advisors?

How might this meeting influence investor sentiment and stock performance?

Could this interaction signal potential future collaborations or investments?

Read Next Article

Shree Ganesh Remedies Files Earnings Call Transcript

0 min read Updated on 20 May 2026, 11:16 PM

Reviewed by

Suketu GScanX News Team

Add as a preferred
source on Google

AI Summary

Shree Ganesh Remedies Limited has submitted the transcript of its Q1FY27 earnings conference call to BSE Limited. The transcript, corresponding to the meeting held on May 15, 2026, was filed on May 20, 2026, by Company Secretary Aditya Vikrambhai Patel under Regulation 30. The document is accessible via the investor relations section of the company's website.

*this image is generated using AI for illustrative purposes only.

Shree Ganesh Remedies Limited has submitted the transcript of its Q1FY27 earnings conference call to BSE Limited. The company informed the exchange that the transcript of the meeting held on May 15, 2026, has been uploaded to the investor relations section of its website.

Regulatory Submission Details

The filing, addressed to the Listing Department of BSE Limited at Phiroze Jeejeebhoy Towers, Mumbai, confirms the availability of the transcript. The document was digitally signed by Aditya Vikrambhai Patel, Company Secretary, on May 20, 2026, at 20:15:13 IST.

Key details of the submission are outlined below:

Parameter:	Details
Event:	Earnings Call – Q1FY27
Earnings Call Date:	May 15, 2026
Filing Date:	May 20, 2026
Exchange:	BSE Limited
Regulatory Compliance:	Regulation 30
Authorized Signatory:	Aditya Vikrambhai Patel, Company Secretary

Filing Authorization

The submission requests BSE to take the transcript on record. The company has provided a web link to access the document on its official website, www.ganeshremedies.com . This filing follows the earlier submission of the audio recording on May 16, 2026.

Historical Stock Returns for Shree Ganesh Remedies

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.43%	+6.94%	+11.35%	+54.83%	+17.67%	+98.35%

What key financial metrics and guidance did Shree Ganesh Remedies management highlight during the Q1FY27 earnings call that could signal future revenue growth trajectory?

How does Shree Ganesh Remedies' Q1FY27 performance compare to its pharmaceutical sector peers, and what competitive positioning changes might emerge in subsequent quarters?

Are there any new product launches, regulatory approvals, or geographic expansion plans discussed in the Q1FY27 call that could materially impact the company's FY27 outlook?